The delisting risk is removed, which is a positive near-term catalyst. However, the company's cash runway is limited (through September 2026 per prior filings) and going-concern doubts persist. Monitor for further capital raises or business updates that could impact the stock's ability to maintain the $1.00 bid price.
Price Chart
Executive Summary
Outlook Therapeutics received a letter from Nasdaq on June 26, 2026, confirming that it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after its common stock closed at $1.00 or above for ten consecutive business days from June 11 to June 25, 2026. This resolves the delisting notice received on February 18, 2026, and the matter is now closed, removing a significant overhang on the stock.
Key Facts
- Nasdaq confirmed compliance with minimum bid price rule on June 26, 2026
- Stock closed at or above $1.00 for ten consecutive business days (June 11–25, 2026)
- Delisting matter is now closed
- Previously notified of non-compliance on February 18, 2026
Financial Impact
No financial figures provided in this filing. The removal of delisting risk may improve liquidity and institutional ownership prospects.
Risk Factors
- Company still faces substantial doubt about its ability to continue as a going concern
- Cash runway only expected into September 2026 based on prior filings
- Potential need for additional dilutive financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078337 |
| Document: 0001104659-26-078337-index-headers.html | 0001104659-26-078337 |
| Document: 0001104659-26-078337-index.html | 0001104659-26-078337 |
| Document: 0001104659-26-078337.txt | 0001104659-26-078337 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5930 (+21.60%) |
Aug 14, 2026 7w ago | 424B5 | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5930 (+21.60%) |
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5930 (+21.60%) |
Aug 14, 2026 7w ago | Press Release | $0.7564 $0.6379 | ▼ −15.67% | ▼ −13.67% | $0.5930 (−21.60%) |
Aug 13, 2026 7w ago | Press Release | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5930 (+33.28%) |
Aug 12, 2026 7w ago | 8-K | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5930 (+33.28%) |
Jul 24, 2026 9w ago | 8-K | $1.07 $0.6090 | ▼ −42.82% | ▼ −46.12% | $0.5930 (−44.32%) |
Jul 24, 2026 10w ago | Press Release | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5930 (−57.79%) |
Jul 23, 2026 10w ago | 8-K | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5930 (−57.79%) |
Jul 22, 2026 10w ago | EFFECT | $1.34 $0.6901 | ▼ −48.50% | ▼ −51.40% | $0.5930 (−55.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access